Introducing A NEW Drug Monitoring Assay | Anti-Vedolizumab (Entyvio®)
Posted by Brandon Savela on May 31st 2017
This message is to inform you about a new development concerning our ImmunoGuide® Drug Monitoring product range.
We are pleased to present our new
Anti-Vedolizumab (Entyvio®) ELISA
… read more